.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Chubb
Accenture
Cerilliant
Citi
Baxter
Deloitte
Daiichi Sankyo
Fish and Richardson
Moodys

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077684

« Back to Dashboard

NDA 077684 describes TRETINOIN, which is a drug marketed by Anchen Pharms, Barr Labs Inc, Glenmark Pharms Ltd, Allergan Sales Llc, Perrigo Pharma Intl, Zo Skin Health, Mylan Pharms Inc, Teva Pharms, and Wockhardt, and is included in sixteen NDAs. It is available from eighteen suppliers. Additional details are available on the TRETINOIN profile page.

The generic ingredient in TRETINOIN is tretinoin. There are twenty-four drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the tretinoin profile page.

Summary for 077684

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antineoplastics
Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 077684

Ingredient-typeRetinoids

Medical Subject Heading (MeSH) Categories for 077684

Suppliers and Packaging for NDA: 077684

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRETINOIN tretinoin CAPSULE;ORAL 077684 ANDA Barr Laboratories Inc. 0555-0808 0555-0808-02 100 CAPSULE, LIQUID FILLED in 1 BOTTLE (0555-0808-02)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength10MG
Approval Date:Jun 22, 2007TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Cerilliant
Accenture
Colorcon
Federal Trade Commission
Express Scripts
Mallinckrodt
Harvard Business School
Teva
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot